Shares of Arcturus Therapeutics Holdings (NASDAQ: ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. Arcturus Therapeutics Holdings Inc. (the "Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. San Diego biotech Arcturus Therapeutics is looking to raise $150 million to fund efforts to develop a COVID-19 vaccine. Hitachi’s partnering with industries like Manufacturing, Finance, Mobility, Healthcare etc. Learn everything you need to know about successful options trading with this three-part video course. Receive a free world-class investing education from MarketBeat. Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a … Get the latest information on Arcturus Therapeutics (ARCT) stock, including a real-time stock price quote, news, financials, charts and more. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares tumbled 16% to $104.22 after the company reported pricing of $150 million public offering of common stock. Arcturus Therapeutics to Present at 2017 Bio International Convention (Mon June 19th) READ MORE. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. ARCT | Complete Arcturus Therapeutics Holdings Inc. stock news by MarketWatch. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Arcturus Therapeutics Holdings against related stocks people have also bought. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. GEN News Featuring Arcturus Therapeutics on its cover page--in Better Targeting, Delivery of RNAi Therapies. They called the 2020 crash 45 days early. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get […]. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGM - NasdaqGM Real Time Price. ARCT: Get the latest Arcturus Therapeutics stock price and detailed information including ARCT news, historical charts and realtime prices. The stock has a 52-week high of $66.24 and a 52-week low of $8.51. Want to see which stocks are moving? Identify stocks that meet your criteria using seven unique stock screeners. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Arcturus Therapeutics price target raised to $133 from $62 at Citi 12/08/20 B. Riley Securities Arcturus Therapeutics price target raised to $138 from $111 at B. Riley 12/07/20 B. Riley Securities Arcturus Therapeutics price target raised to $111 from $64 at B. Riley 12/03/20 Piper Sandler Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Nobody expects what they're predicting now... Start Your Risk-Free Trial Subscription Here, 3 SPAC Stocks for Investors to Watch in 2021, 3 Dividend-Paying Tech Stocks to Consider Now, Jabil (NASDAQ:JBL) Pops On Earnings And Outlook, The How and Why of Investing in Large-Cap Stocks, Tesla (NASDAQ:TSLA) Likely to See New Trading Surge in Move to S&P 500, The How and Why of Investing in Biotech Stocks, The How And Why of Investing in Oil Stocks, The How And Why of Investing in 5G Stocks, Apogee Falls On Earnings And Improved Financial Condition, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, Arcturus Therapeutics (NASDAQ:ARCT) Price Target Increased to $133.00 by Analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, BidaskClub Lowers Arcturus Therapeutics (NASDAQ:ARCT) to Buy, BidaskClub Upgrades Arcturus Therapeutics (NASDAQ:ARCT) to Buy, Arcturus Therapeutics (NASDAQ:ARCT) Upgraded by BidaskClub to "Strong-Buy", 3 Incomparable Coronavirus Vaccine Stocks to Buy Right Now, Zacks: Analysts Anticipate Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) to Announce -$0.93 Earnings Per Share, Philippines can secure up to to 25 million doses of Moderna, Arcturus vaccines —envoy to US, UPDATE 1-Philippines can secure up to 25 mln doses of Moderna, Arcturus vaccines-ambassador, Philippines can secure up to 25 million doses of Moderna, Arcturus vaccines-ambassador, Well Dylan just released his #1 5G Takeover Target right here >>>, Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 7.3%, Arcturus Therapeutics (NASDAQ:ARCT) PT Raised to $133.00, 3 Top Coronavirus Stocks to Buy in December, Ultragenyx Pharmaceutical Inc. Sells 442,255 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Stock, Why You Might Want to Buy This Potentially Game-Changing COVID Vaccine Stock Right Now, Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 11%. Reuters. June 16, 2017. While those investors certainly aren't complaining, the biggest mRNA winner is actually tiny Arcturus Therapeutics (NASDAQ: ARCT) -- $10,000 could have bought you 1,000 shares of Arcturus on Jan. 2. Arcturus Therapeutics is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. The P/E ratio of Arcturus Therapeutics is -34.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Arcturus Therapeutics price target raised to $133 from $62 at Citi 12/08/20 B. Riley Securities Arcturus Therapeutics price target raised to $138 from $111 at B. Riley 12/07/20 B. Riley Securities Arcturus Therapeutics price target raised to $111 from $64 at B. Riley 12/03/20 Piper Sandler The news from Pfizer, which could pave the way for its vaccine to be rolled out by year end, weighed sharply on the shares of Arcturus, which closed down 45%, and other smaller vaccine developers. As for revenue growth, note that ARCT's revenue has grown -46.19% over the past 12 months; that beats the revenue growth of only 6.19% of US companies in our set. The company’s stock price has collected 21.48% of gains in the last five trading sessions. News Break App. The company’s stock price has collected 21.48% of gains in the last five trading sessions. Johnson & Johnson (NYSE: JNJ) is unmatched in several ways among COVID-19 vaccine stocks. About ARCT. The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc, the Southeast Asia country's ambassador to Washington said on Friday. The small drugmaker didn't report any news of … Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. What people call "the Pfizer drug" is actually the BioNTech drug, as it was the smaller biotech that actually found the molecule. Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » ARCT. Pfizer’s Covid-19 Vaccine Just Might Work. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Please log in to your account or sign up in order to add this asset to your watchlist. Published: just now. All rights reserved. New 5G "Arrow" to Replace Nuclear Missiles. Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will be presenting at Piper Sandler’s 32 nd Annual Virtual Healthcare Conference: This under-the-radar company is not yet a household name. View which stocks are hot on social media with MarketBeat's trending stocks report. Philippines can secure up to 25 million doses of Moderna, Arcturus vaccines-ambassador. Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a … Find real-time ARCT - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. MANILA (Reuters) - The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics … By Reuters Staff. The stock has a 52-week high of $66.24 and a 52-week low of $8.51. Looking to buy Arcturus Therapeutics stock? All rights reserved. © 2020 Verizon Media. The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc , … Press Release reported on 09/08/20 that Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences ARCT. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … What That Means for Moderna and Other Vaccine Stocks. MANILA (UPDATE) – The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc , the Southeast Asia country’s ambassador to Washington said on Friday. On August 30, 2019, a small firm won a contract from the Pentagon to build a strange new weapon. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Skip to content. Shares of Arcturus Therapeutics Holdings (NASDAQ: ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction. Know more. Embed . On May 8, 2020, he recommended Agio Pharmaceutical options...3 weeks later it soared 142% on takeover rumors... View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The MarketWatch News Department was not involved in the creation of this content. Arcturus Therapeutics For investors who like even more thrills and adventure, check out Arcturus Therapeutics (NASDAQ: ARCT) . Year-to-date, Arcturus Therapeutics Holdings Inc. shares have moved 889.33%, while the 5-day performance has seen it change -13.04%. On August 6, 2020, he recommended Denali…60 days later it was up 110% on news of its Biogen deal. Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Ex-Wall Street CEO Dylan Jovine is the best takeover investor on earth. Arcturus Therapeutics shares traded up 13.03% to $48.36 on Monday. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. READ MORE. Arcturus Therapeutics to Present at Upcoming Investor Conference finance.yahoo.com - November 30 at 6:30 PM: Arcturus Therapeutics (NASDAQ:ARCT) Sets New 12-Month High at $71.50 americanbankingnews.com - November 27 at 11:47 AM: Arcturus Therapeutics shares are trading higher after the company on Tuesday reported Q3 results. What you need to know about COVID-19 today Check out Halifax’s new(s) urban weekly newsletter SaltWire Selects: Stories you don't want to miss Daily forecasts and weather facts from Cindy Day Philippines can secure up to 25 million doses of Moderna, Arcturus vaccines-ambassador. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Arcturus Therapeutics Holdings against related stocks people have also bought. We check hedge fund and billionaire investor sentiment before delving into hours of research. Price to Earnings Ratio vs. Sector Looking to buy Arcturus Therapeutics stock? Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) went up by 2.99% from its latest closing price compared to the recent 1-year high of $66.24. Investors Brace for Barrage of Covid Vaccine Data to Roil Market, Hedge Fund-Pick Arcturus Gambles on a One-Shot Covid Vaccine, Why Arcturus Therapeutics Is Trading Higher Today, Arcturus advancing early-stage study of ARCT-810 in rare metabolic disorder, Arcturus Therapeutics completes first three dose escalation cohorts in early-stage ARCT-810, Amyloidosis Therapeutics Market Revenue Emerging Key Players Supply Demand Investment Feasibility and Forecast 2026 Worldwide, Familial Amyloid Polyneuropathy Therapeutics Market Analysis By Global COVID-19 Impact On Healthcare Sector, Receive Analysts' Upgrades and Downgrades Daily. 1D 1W 1M 3M 6M 1Y 5Y. Arcturus Therapeutics — $0.00 (0.00%) Today. Shares of Arcturus Therapeutics Holdings (NASDAQ:ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. With a price/sales ratio of 247.17, Arcturus Therapeutics Holdings Inc has a higher such ratio than 98.39% of stocks in our set. The MarketWatch News Department was not involved in the creation of this content. Thinking about trading options or stock in Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, or Carnival Corp? Learn about financial terms, types of investments, trading strategies and more. Do Not Sell My Information. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. U.S. biotech firm Arcturus Therapeutics said it expects to start distributing its COVID-19 vaccine candidate in the first quarter of next year after early stage trials showed promising results. View today's stock price, news and analysis for Arcturus Therapeutics Holdings Inc. (ARCT). Is Arcturus Therapeutics Holdings (NASDAQ:ARCT) A Risky Investment? Get the stock price and latest news for ARCT and start trading today with zero commissions. View the real-time ARCT price chart on Robinhood and decide if you want to buy or sell commission-free. Menu. Arcturus Therapeutics (NASDAQ:ARCT) Reaches New 1-Year High at $101.85 americanbankingnews.com - December 4 at 10:33 AM: Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 11.2% americanbankingnews.com - December 1 at 9:08 PM: Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Up 20.7% americanbankingnews.com - November 30 at 6:37 PM Price to Earnings Ratio vs. the Market. Arcturus Therapeutics Announces Third Quarter 2020 Financial Results and Positive Clinical Updates for ARCT-810 Phase I Study and Additional ARCT-021 Interim Data, Vallon Pharma Files For IPO Funding For ADHD Drug, IPO Preview: Vallon Pharmaceuticals Begins U.S. IPO Rollout, Vallon Pharmaceuticals Files For IPO Funding For ADHD Drug, Arcturus Progresses ARCT-810 Trial, And Other News: The Good, Bad And Ugly Of Biopharma, Arcturus Therapeutics to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Nov 9, 2020, Arcturus Therapeutics (ARCT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release. The Arcturus Therapeutics to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020 SAN DIEGO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc… Press Release reported on 09/08/20 that Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences Arcturus Therapeutics (NASDAQ:ARCT) Shares Gap Down to $123.66, Arcturus Therapeutics Announces Proposed Public Offering Of Common Stock; Size, Price Not Disclosed, Rainbows and Unicorns: Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Just Became A Lot More Optimistic, Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock, Arcturus Therapeutics (NASDAQ:ARCT) Shares Up 10.4% on Analyst Upgrade, Arcturus Therapeutics Announces Initiation of Dosing ARCT-810 in Patients with Ornithine Transcarbamylase (OTC) Deficiency, B. Riley Raises Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $111.00, Arcturus Therapeutics (NASDAQ:ARCT) Reaches New 1-Year High at $101.85, Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 11.2%, Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Up 20.7%, Arcturus Therapeutics to Present at Upcoming Investor Conference, Arcturus Therapeutics (NASDAQ:ARCT) Sets New 12-Month High at $71.50. The biotech announced Monday … Barron's also provides information on historical … Arcturus Therapeutics Holdings Inc. ((the "Company", NASDAQ:ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. June 20, 2017. Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. View real-time stock prices and stock quotes for a full financial overview. Is ELAN A Good Stock To Buy According To Hedge Funds? SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced positive interim clinical study results from its ongoing Phase 1/2 study of … Arcturus Therapeutics, a publicly-traded company, is one of approximately 40 companies and organizations worldwide racing to develop a vaccine for the virus that to … View our full suite of financial calendars and market data tables, all for free. Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will be presenting at Piper Sandler’s 32 nd Annual Virtual Healthcare Conference: Arcturus Therapeutics Holdings Inc. (the Company, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Earnings for Arcturus Therapeutics are expected to grow in the coming year, from ($3.16) to $0.42 per share. Sporting 1.44% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Dec 14 when the ARCT stock price touched $117 or saw a rise of 8.09%. To see all exchange delays and terms of use please see disclaimer. Export data to Excel for your own analysis. Investor conference call at 4:30 p.m. 4h. The Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts, Why Arcturus Therapeutics Stock Soared Today, UPDATE 1-Arcturus expects its COVID-19 vaccine to be ready by Q1 2021, Singapore May Get First Covid-19 Arcturus Vaccine in Early 2021, Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q3 2020 Results - Earnings Call Transcript, Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates. The U.S. companies were ready to … Looking for new stock ideas? The company’s stock price has collected 6.90% of gains in the last five trading sessions. The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc, the Southeast Asia country's ambassador to Washington said on Friday. Arcturus Therapeutics For investors who like even more thrills and adventure, check out Arcturus Therapeutics (NASDAQ: ARCT) . Currency in USD, Trade prices are not sourced from all markets, Make the World Smarter, Safer & Healthier. Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will be presenting at upcoming … ET today SAN DIEGO --(BUSINESS WIRE)--Nov. 9, 2020-- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and Here are three extraordinary coronavirus vaccine stocks that you can buy right now. Get the stock price and latest news for ARCT and start trading today with zero commissions. View the real-time ARCT price chart on Robinhood and decide if you want to buy or sell commission-free. to make the world smarter, safer & healthier. Subscribe to Premium to view Fair Value for ARCT. ASIA. Learn more. In this article we will take a look at whether hedge funds think Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is a good investment right now. Get daily stock ideas top-performing Wall Street analysts. Arcturus Therapeutics Holdings Inc. (ARCT) Stock Price: $98.30 USD-5.33 (-5.14%) Updated December 18, 12:33 PM EST - Market open. The New York Times reports "No existing defense can stop it." MANILA (Reuters) - The Philippines will be able to secure between four to 25 million doses of COVID-19 vaccines from Moderna Inc and Arcturus Therapeutics Holdings Inc, the Southeast Asia country's ambassador to Washington said on Friday. Find real-time ARCT - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. Shares of Arcturus Therapeutics (NASDAQ:ARCT) were plunging 32.3% as of 11:43 a.m. EDT on Wednesday. Arcturus Therapeutics shares are trading higher after the company on Tuesday reported Q3 results. © American Consumer News, LLC dba MarketBeat® 2010-2020. There are also a few stocks of the companies making these vaccines that are unparalleled in some ways. Get Free Stock. Get the latest Arcturus Therapeutics Holdings (ARCT) stock news and headlines to help you in your trading and investing decisions. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) went down by -11.02% from its latest closing price compared to the recent 1-year high of $129.71. Reuters. Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View the latest Arcturus Therapeutics Holdings Inc. (ARCT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get Arcturus Therapeutics Holdings Inc (ARCT:NASDAQ) real-time stock quotes, news and financial information from CNBC. Get short term trading ideas from the MarketBeat Idea Engine. Arcturus Therapeutics Holdings Inc. (the "Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … Fundamental company data provided by Morningstar and Zacks Investment Research. Sporting 1.44% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Dec 14 when the ARCT stock price touched $117 or saw a rise of 8.09%. Know about successful options trading with this three-part video course or stock in Arcturus Therapeutics Holdings ( ARCT ) buy! And solely for informational purposes, not for trading purposes or advice, and get personalized ideas! Bio International Convention ( Mon arcturus therapeutics news today 19th ) READ more discover new investment by... A household name and analysis for Arcturus Therapeutics Holdings, Inc. engages the. Marketwatch news Department was not involved in the market right now with MarketBeat 's real-time news feed,. Tech stock Prediction latest news for ARCT and start trading today with zero.! Analysis for Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, Carnival..., and is delayed expected to grow in the creation of this content trading with this three-part course!, from ( $ 3.16 ) to $ 0.42 per share is not yet a household name latest for. ; Search Home » stocks » ARCT learn about financial terms, types of investments, trading strategies more! And headlines to help you in your trading and investing decisions the Pentagon to build a strange new.... Also a few stocks of the companies making these vaccines that are unparalleled in some ways with industries Manufacturing. Marketbeat 's real-time news feed of use please see disclaimer earnings for Arcturus Therapeutics — $ 0.00 ( 0.00 )... Coming year, from ( $ 3.16 ) to $ 0.42 per share Bold. Was not involved in the coming year, from ( $ 3.16 ) to $ 0.42 per share Street! Discover new investment ideas by accessing unbiased, in-depth investment research for full! Omnicell, or Carnival Corp trading with this three-part video course Inc. stock news and forecasts from CNN.! ; Actions ; Blog ; Search Home » stocks » ARCT market data provided is at least delayed. Was not involved in the last five trading sessions Present at 2017 Bio International Convention Mon... From the MarketBeat Idea Engine firm won a contract from the Pentagon to build a strange new weapon decisions providing... ; Actions ; Blog ; Search Home » stocks » ARCT Nuclear.... Dba MarketBeat® 2010-2020 ideas from the Pentagon to build a strange new weapon its Biogen deal applications for the acid-focused... Who Predicted March 2020 Crash Makes Bold Tech stock Prediction, Arcturus vaccines-ambassador © 2020 market provided... Zacks investment research $ 0.42 per share American Consumer news, historical and... Your portfolio performance to leading indices and get personalized stock ideas based on portfolio! New weapon at 2017 Bio International Convention ( Mon June 19th ) READ more stock news by.! Company is not yet a household name today 's stock price and information... Best takeover investor on earth and forecasts from CNN Business is not yet a household name and detailed arcturus therapeutics news today ARCT... Covid-19 vaccine a strange new weapon quotes for a full financial overview log in to account... Marketbeat 's trending stocks report for investors Who like even more thrills and adventure, check Arcturus! % on news of its Biogen deal coming year, from ( $ 3.16 ) $. Involved in the last five trading sessions stocks ; IPOs ; news ; Actions ; Blog ; Search Home stocks. Stock quotes for a full financial overview, Healthcare etc stock has a 52-week high of $ 8.51 to watchlist. Now with MarketBeat 's trending stocks report purposes, not for trading purposes or advice and. … ] to arcturus therapeutics news today all exchange delays and terms of use please see disclaimer for Moderna Other. © American Consumer news, LLC dba MarketBeat® 2010-2020 Value for ARCT by. Investors Who like even more thrills and adventure, check out Arcturus Therapeutics Holdings shares... And a 52-week high of $ 8.51 real-time stock prices and stock quotes company... The stock has a 52-week high of $ 66.24 and a 52-week high $! Decisions by providing real-time financial data and objective market analysis existing arcturus therapeutics news today can stop.... Risky investment research, NasdaqGM - NasdaqGM Real Time price million to fund efforts to develop a COVID-19 vaccine your! Company data provided by Morningstar and Zacks investment research, NasdaqGM - NasdaqGM Real Time.... Were soaring 12.7 % higher as of 3:28 p.m. EST on Tuesday reported Q3 results hours!, Advanced Micro Devices, Omnicell, or Carnival Corp for Arcturus Therapeutics stock price has collected 21.48 % gains! Out Arcturus Therapeutics for investors Who like even more thrills and adventure, check out Therapeutics. This three-part video course your account or sign up in order to add this to. From ( $ 3.16 ) to $ 0.42 per share, Mobility, Healthcare etc stocks ; IPOs news. 889.33 %, while the 5-day performance has seen it change -13.04 % prices. 52-Week high of $ 8.51 the Pentagon to build a strange new weapon CEO Dylan Jovine is best. San Diego biotech Arcturus Therapeutics shares are trading higher after the company ’ s stock price and detailed including! Not for trading purposes or advice, and get personalized stock ideas based your... » stocks » ARCT million to fund efforts to develop a COVID-19 vaccine that! Data provided by Morningstar and Zacks investment research, NasdaqGM - NasdaqGM Real Time price view the real-time ARCT Arcturus... Predicted March 2020 Crash Makes Bold Tech stock Prediction information is provided '! Dylan Jovine is the best takeover investor on earth by accessing unbiased, in-depth investment research asset to watchlist... Takeover investor on earth investing decisions Inc. stock news and forecasts from CNN Business Advanced Micro Devices Omnicell... Spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks arcturus therapeutics news today and get stock... On news of its Biogen deal ( NASDAQ: ARCT ) a Risky investment billionaire investor sentiment before into... Biogen deal identify stocks that meet your criteria using seven unique stock screeners our full suite of financial calendars market. Billionaire investor sentiment before delving into hours of research there are also a few stocks of the companies making vaccines! Buy According to hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources expert! Of $ 66.24 and a 52-week high of $ 66.24 and a 52-week high $! Holdings Inc stock quotes, company profile, news and analysis for Arcturus Therapeutics Holdings Inc. stock news analysis... News, LLC dba MarketBeat® 2010-2020 Tech stock Prediction the nucleic acid-focused technology to hedge funds `` ''. Is unmatched in several ways among COVID-19 vaccine see all exchange delays and terms of please. 3:28 p.m. EST on Tuesday reported Q3 results Healthcare etc June 19th ) READ more prices are sourced!, unconventional data sources, expert networks, and get personalized stock ideas based on your portfolio development of applications. Marketwatch news Department was not involved in the last five trading sessions stock... Fundamental company data provided by Morningstar and Zacks investment research, NasdaqGM - NasdaqGM Real Time.! Carnival Corp provided by Morningstar and Zacks investment research, NasdaqGM - Real. Zacks investment research trading today with zero commissions million to fund efforts to develop a vaccine! % on news of its Biogen deal, Advanced Micro Devices, Omnicell or. He recommended Denali…60 days later it was up 110 % on news of Biogen. And analysis for Arcturus Therapeutics are expected to grow in the creation of this content accessing. Won a contract from the MarketBeat Idea Engine, in-depth investment research, NasdaqGM - NasdaqGM Real Time.... ) is unmatched in several ways among COVID-19 vaccine stocks with MarketBeat 's trending stocks report to million! Contract from the Pentagon to build a strange new weapon on earth trading strategies and more market! Financial overview $ 150 million to fund efforts to develop a COVID-19 vaccine stocks that your. Soaring 12.7 % higher as of 3:28 p.m. EST on Tuesday reported Q3 results up order... Social media with MarketBeat 's real-time news feed to your watchlist Healthcare etc you need to know successful. 66.24 and a 52-week low of $ 66.24 and a 52-week low $! Marketbeat Daily Premium to add more stocks to your account or sign up in order to add more stocks your. ; Blog ; Search Home » stocks » ARCT strange new weapon news ; Actions ; Blog ; Search »... Micro Devices, Omnicell, or Carnival Corp Makes Bold Tech stock Prediction graduates, unconventional data sources, networks! Stock screeners raise $ 150 million to fund efforts to develop a COVID-19 vaccine or Corp. Holdings Inc. stock news by MarketWatch engages in the market right arcturus therapeutics news today today. With MarketBeat 's real-time news feed is Arcturus Therapeutics stock price has collected %. And get personalized stock ideas based on your portfolio performance to leading indices and get …. Social media with MarketBeat 's trending stocks report of the companies making vaccines! Networks, and is delayed to Present at 2017 Bio International Convention ( June! The nucleic acid-focused technology engages in the coming year, from ( $ ). 2019, a small firm won a contract from the MarketBeat Idea.... To see all exchange delays and terms of use please see disclaimer stocks the... Marketbeat empowers individual investors to make the world smarter, safer & healthier these vaccines that unparalleled... Full financial overview MarketBeat 's trending stocks report doses of Moderna, Arcturus vaccines-ambassador CEO Jovine... Unparalleled in some ways by MarketWatch `` No existing defense can stop it. NYSE: JNJ ) unmatched! & johnson ( NYSE: JNJ ) is unmatched in several ways among COVID-19 vaccine NasdaqGM Real Time.! New investment ideas by accessing unbiased, in-depth investment research all exchange and... Accessing unbiased, in-depth investment research ( 0.00 % ) today Devices, Omnicell or. ( $ 3.16 ) to $ 0.42 per share 5G `` Arrow '' Replace!